Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China
· Delayed Price · Currency is CNY 36.04
+0.55 (1.55%)
At close: Apr 29, 2026
SHA:603014 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 482.3 | 449.37 | 442.07 | 314.96 | 259.82 |
| Depreciation & Amortization | 247.59 | 241.24 | 238.25 | 238.3 | 201.41 |
| Other Amortization | 4.1 | 4.27 | 7.03 | 6.61 | 5.33 |
| Loss (Gain) From Sale of Assets | -0.02 | -0.2 | -0.09 | 0.01 | -0.01 |
| Asset Writedown & Restructuring Costs | 3.41 | 2.75 | 3.65 | 3.01 | 5.62 |
| Loss (Gain) From Sale of Investments | -0.99 | -0.22 | -0.11 | - | -15.86 |
| Stock-Based Compensation | - | - | 27.11 | 52.96 | 71.02 |
| Provision & Write-off of Bad Debts | 1.8 | 18.69 | 21.18 | 37.23 | -0.03 |
| Other Operating Activities | -27.97 | -6.79 | -25.11 | -19.14 | 46.71 |
| Change in Accounts Receivable | 22.55 | -120.61 | 27.5 | -188.05 | -222.91 |
| Change in Inventory | -73.81 | 142.77 | -262.4 | -117.45 | -101.94 |
| Change in Accounts Payable | 133.83 | -170.24 | -196.98 | 413.24 | 257.92 |
| Change in Other Net Operating Assets | 1.96 | 10.97 | - | - | - |
| Operating Cash Flow | 793.71 | 572.3 | 288.14 | 727.33 | 504.89 |
| Operating Cash Flow Growth | 38.69% | 98.62% | -60.38% | 44.06% | - |
| Capital Expenditures | -159.85 | -179.3 | -232.81 | -279.8 | -401.25 |
| Sale of Property, Plant & Equipment | 0.31 | 3.88 | 6.87 | 8.1 | 16.88 |
| Investment in Securities | -1,363 | -259.91 | 37.54 | 10.2 | 5.58 |
| Other Investing Activities | 30.94 | 56 | 0.89 | 19.47 | 0.15 |
| Investing Cash Flow | -1,492 | -379.34 | -187.51 | -242.03 | -378.63 |
| Short-Term Debt Issued | - | 3.18 | 6.64 | 480.07 | 677.95 |
| Total Debt Issued | - | 3.18 | 6.64 | 480.07 | 677.95 |
| Short-Term Debt Repaid | - | - | -41.8 | -1,238 | -765.02 |
| Long-Term Debt Repaid | -8.76 | -8.26 | -7.48 | -82.69 | - |
| Total Debt Repaid | -8.76 | -8.26 | -49.28 | -1,321 | -765.02 |
| Net Debt Issued (Repaid) | -8.76 | -5.08 | -42.63 | -840.82 | -87.08 |
| Issuance of Common Stock | 1,216 | - | - | 624.21 | - |
| Common Dividends Paid | -65.83 | - | -0.49 | -18.84 | -42.71 |
| Other Financing Activities | -98.22 | -10.36 | -4.23 | 13.33 | -116.19 |
| Financing Cash Flow | 1,043 | -15.44 | -47.35 | -222.11 | -245.97 |
| Foreign Exchange Rate Adjustments | 0.19 | -0.51 | 0.84 | 3.26 | -0.9 |
| Net Cash Flow | 345.14 | 177.02 | 54.11 | 266.45 | -120.61 |
| Free Cash Flow | 633.86 | 393 | 55.33 | 447.53 | 103.64 |
| Free Cash Flow Growth | 61.29% | 610.28% | -87.64% | 331.80% | - |
| Free Cash Flow Margin | 16.82% | 10.90% | 1.57% | 13.06% | 3.56% |
| Free Cash Flow Per Share | 1.60 | 1.06 | 0.15 | 1.23 | 0.29 |
| Cash Income Tax Paid | 318.55 | 343.06 | 302.29 | 203.49 | 265.76 |
| Levered Free Cash Flow | 500.49 | 361.26 | 94.07 | 259.12 | - |
| Unlevered Free Cash Flow | 500.96 | 361.63 | 94.6 | 270.58 | - |
| Change in Working Capital | 83.49 | -136.81 | -425.84 | 93.38 | -69.13 |
Source: S&P Capital IQ. Standard template. Financial Sources.